海港治疗公司 SPTX
$21.50 +$1.11 (+5.44%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $21.50 0.00%
开盘$20.85
昨收$20.39
当日区间$19.77 – $21.75
成交量227.0K
市值$1.15B
市盈率（TTM）–
股息率–
SPTX 相关新闻
匹配 Seaport Therapeutics 或代码 SPTX 的头条新闻，按最新排序。
- Citi Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $35
- H.C. Wainwright Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $50
- JonesTrading Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $32
- Analysts Conflicted on These NA Names: SailPoint, Inc. (SAIL) and Seaport Therapeutics, Inc. (SPTX)
- Analysts Offer Insights on NA Companies: Seaport Therapeutics, Inc. (SPTX), Navan, Inc. Class A (NAVN) and International Business Machines (IBM)
- JonesTrading Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $32
- Stifel Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $30
- Seaport Therapeutics, Inc. (SPTX) Gets a Buy From Stifel Nicolaus
- Wolfe Research Initiates Seaport Therapeutics(SPTX.US) With Hold Rating
- H.C. Wainwright Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $50
- J.P. Morgan Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $42
- Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX) 正面
- Citi Sticks to Its Buy Rating for Seaport Therapeutics, Inc. (SPTX)
- Leerink Partners Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $35
- J.P. Morgan Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $42
暂无评论——快来第一个聊聊 SPTX。
登录后参与讨论。